LOS ANGELES, Jan 31 (Reuters) - Biotechnology company Isis Pharmaceuticals Inc. (ISIS.O: Quote, Profile, Research) said on Thursday that Abbott Laboratories (ABT.N: Quote, Profile, Research) is investing up to $40 million in Isis' mass spectrometer subsidiary Ibis Biosciences Inc.
